Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutation, deprivation and poor prognosis in primary breast cancer.

British journal of cancer - 16 Feb 2010

Baker L, Quinlan P R, Patten N, Ashfield A, Birse-Stewart-Bell L-J, McCowan C, Bourdon J-C, Purdie C A, Jordan L B, Dewar J A, Wu L, Thompson A M

Abstract excerpt

BACKGROUND: The deprivation gap for breast cancer survival remains unexplained by stage at presentation, treatment, or co-morbidities. We hypothesised that p53 mutation might contribute to the impaired outcome observed in patients from deprived communities. METHODS: p53 mutation status was determ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Prognosis

Share to Social Class

Share to Survival Analysis

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 20104224
DOI: 10.1038/sj.bjc.6605540
PMCID: PMC2837559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20104224-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

p53 mutation, deprivation and poor prognosis in primary breast cancer.PMID 20104224Read ↗

p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.Semantic proximity Read ↗

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.Semantic proximity Read ↗

P53 abnormalities and outcomes in colorectal cancer: a systematic review.Semantic proximity Read ↗

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.Semantic proximity Read ↗

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment.Semantic proximity Read ↗

Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers.Semantic proximity Read ↗

Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom.Semantic proximity Read ↗

TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.Semantic proximity Read ↗

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.Semantic proximity Read ↗

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.Semantic proximity Read ↗

Prognostic value of p53 molecular status in high-risk primary breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.